glp 1 drug liraglutide may protect against dementia Weight-Loss Drugs for Dementia, Alzheimer's: Early Study Looks Promising Cardiovascular Protection with a Long-Acting

Designed to complement your GLP-1 journey

GLP-1 drugs like Ozempic and Mounjaro may offer real benefits for people with type 1 diabetes: less insulin, flatter CGM curves, and emerging evidence for heart and kidney protection.

Methods This is a cohort study combining several population-wide databases and covering a Spanish population of five million inhabitants, including all adults with obesity who initiated treatment with either GLP-1RA or SGLT-2i for type 2 diabetes from 2015 to 2021

Loss of muscle mass and strength not only impairs mobility and quality of life, but also worsens insulin resistance, accelerates cardiometabolic decline and increases mortality risk

The GLP-1 market is expected to hit $200 billion by 2031, according to a new study.

The GLP-1 receptor assay is a powerful tool for the identification of GLP-1 receptor agonists aimed at treating obesity and type 2 diabetes